Lefebvre H, Contesse V, Delarue C, Vaudry H, Kuhn J M
European Institute for Peptide Research, Group for Hormone Research, CHU of Rouen, France.
Horm Metab Res. 1998 Jun-Jul;30(6-7):398-403. doi: 10.1055/s-2007-978904.
Serotonin (5-HT) plays a pivotal role in the regulation of the hypothalamo-pituitary-adrenal axis. In particular, 5-HT is involved in the stimulation of ACTH secretion during stress. Recent data indicate that, at the adrenal level, 5-HT acts as a local regulator of corticosteroid secretion. The presence of 5-HT in the adrenal gland has been demonstrated immunohistochemically and biochemically in various species including frog, mouse, rat and human. In the mouse, 5-HT has been detected in nerve fibers while, in the frog and rat, 5-HT appears to be sequestered in chromaffin cells. In man, 5-HT is stored in perivascular mast cells. In vivo and in vitro studies have shown that 5-HT stimulates mineralo- and glucocorticoid secretion from adrenal cells. In rat, the type of receptor involved in the corticotropic effect of 5-HT is still controversial. In the frog and the human, the effect of 5-HT on the adrenal cortex is mediated through a 5-HT4 receptor subtype positively coupled to adenylyl cyclase and calcium influx. Clinical studies indicate that 5-HT4 receptor agonists stimulate aldosterone secretion in healthy volunteers and in patients with aldosterone disorders. The 5-HT4 receptor agonist cisapride and angiotensin II exert additive effects on aldosterone secretion. In contrast, cisapride has no influence on ACTH-induced aldosterone release. Collectively, these findings suggest that intra-adrenal 5-HT stimulates the secretory activity of adrenocortical cells through a paracrine mode of communication involving a 5-HT4 receptor type. Serotonergic control of corticosteroid production may be involved in the physiological control of the activity of the adrenal cortex, in particular during inflammatory stress. 5-HT may also be implicated in the pathophysiology of aldosterone disorders.
血清素(5-羟色胺,5-HT)在下丘脑-垂体-肾上腺轴的调节中起关键作用。特别是,5-HT参与应激期间促肾上腺皮质激素(ACTH)分泌的刺激过程。最近的数据表明,在肾上腺水平,5-HT作为皮质类固醇分泌的局部调节因子发挥作用。通过免疫组织化学和生物化学方法已在包括青蛙、小鼠、大鼠和人类在内的各种物种的肾上腺中证实了5-HT的存在。在小鼠中,已在神经纤维中检测到5-HT,而在青蛙和大鼠中,5-HT似乎被隔离在嗜铬细胞中。在人类中,5-HT储存在血管周围的肥大细胞中。体内和体外研究表明,5-HT刺激肾上腺细胞分泌盐皮质激素和糖皮质激素。在大鼠中,参与5-HT促肾上腺皮质激素作用的受体类型仍存在争议。在青蛙和人类中,5-HT对肾上腺皮质的作用是通过与腺苷酸环化酶和钙内流正偶联的5-HT4受体亚型介导的。临床研究表明,5-HT4受体激动剂可刺激健康志愿者和醛固酮紊乱患者的醛固酮分泌。5-HT4受体激动剂西沙必利和血管紧张素II对醛固酮分泌具有相加作用。相比之下,西沙必利对ACTH诱导的醛固酮释放没有影响。总体而言,这些发现表明肾上腺内的5-HT通过涉及5-HT4受体类型的旁分泌通讯模式刺激肾上腺皮质细胞的分泌活动。皮质类固醇生成的5-羟色胺能控制可能参与肾上腺皮质活动的生理调节,特别是在炎症应激期间。5-HT也可能与醛固酮紊乱的病理生理学有关。